Granisetron 2 mg in 10 mL Oral Solution
RxNorm 251426
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 251426 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: granisetron 2 mg in 10 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Granisetron 0.2 mg/ML Oral Solution
(Atom ID: 12339227)
PTPrescribable
Designated preferred name (PT):
Granisetron (as granisetron hydrochloride) 200 microgram/mL oral solution
(Atom ID: 10299369)
SYPrescribable
Synonym (SY):
Granisetron 0.2 mg/ML (granisetron hydrochloride 0.224 mg/ML) Oral Solution
(Atom ID: 3264218)
SYPrescribable
Synonym (SY):
Granisetron 1 mg per 5 mL Oral Solution
(Atom ID: 4258756)
PSNPrescribable
Prescribable Name (PSN):
Granisetron 2 mg in 10 mL Oral Solution
(Atom ID: 12987839)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 mL conventional release oral solution (clinical drug)
(Atom ID: 10313131)
Patient Education
Granisetron
Granisetron is used to prevent nausea and vomiting caused by cancer chemotherapy and radiation therapy. Granisetron is in a class of medications called 5-HT3 receptor antagonists. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting.
[Learn More]
* Please review the disclaimer below.